サマリー

麻酔薬の世界市場 2023-2027
Technavioは、麻酔薬市場をモニターしており、2022年から2027年の間に1億3865万ドル、予測期間中のCAGRは4.35%で加速して成長すると予測しています。当レポートでは、麻酔薬市場の全体的な分析、市場規模と予測、トレンド、成長促進要因、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、癌の有病率の上昇、手術件数の増加、高齢者人口の増加によって牽引されています。
Technavioの麻酔薬市場は以下のようにセグメント化されています：
タイプ別
- 全身麻酔
- 局所麻酔と局部麻酔
投与経路別
- 静脈内投与
- 吸入性
- その他
ジオグラフィー別
- 北アメリカ
- ヨーロッパ
- 亜細亜
- レスト・オブ・ワールド（ROW）
本調査では、全身麻酔に代わる麻酔薬の採用が増加していることが、今後数年間の麻酔薬市場の成長を促進する主要因の1つであるとしています。また、製品の発売数の増加や医療インフラの急速な拡大が、市場の大きな需要につながるとしています。
Technavioは、複数の情報源からのデータを、主要なパラメータの分析によって調査、合成、総括する方法で、市場の詳細な姿を提示します。当社の麻酔薬市場に関するレポートは、以下の分野をカバーしています：
- 麻酔薬市場のサイジング
- 麻酔薬市場予測
- 麻酔薬市場の産業分析
Technavioの強固なベンダー分析は、クライアントが市場での地位を向上させることを目的としており、これに沿って、本レポートでは、AbbVie Inc.、Aspen Pharmacare Holdings Ltd、AstraZeneca Plc、Avet Pharmaceuticals Inc、Baxter International Inc、Dr Reddys Laboratories Ltd.、Eisai Co.株式会社エーザイ、Endo International Plc、Fresenius SE and Co.KGaA、Glenmark Pharmaceuticals Ltd.、Hikma Pharmaceuticals Plc、Maruishi Pharmaceutical Co.Ltd.、Merck and Co.Inc.、Novartis AG、PAION AG、Pfizer Inc.、Piramal Enterprises Ltd.、Septodont Holding、Troikaa Pharmaceuticals Ltd.、B Braun Melsungen AG。また、麻酔薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/anesthesia-drugs-market-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析によって、複数のソースからのデータを調査、合成、要約する方法で、市場の詳細な画像を提示します。また、業界の主要なインフルエンサーを特定することで、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global anesthesia drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global anesthesia drugs market 2017 - 2021 ($ million)
o 4.2 Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.3 Route of Administration Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 General anesthesia - Market size and forecast 2022-2027
o Exhibit 34: Chart on General anesthesia - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on General anesthesia - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on General anesthesia - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on General anesthesia - Year-over-year growth 2022-2027 (%)
o 6.4 Local and regional anesthesia - Market size and forecast 2022-2027
o Exhibit 38: Chart on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
o Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 45: Chart on Comparison by Route of Administration
o Exhibit 46: Data Table on Comparison by Route of Administration
o 7.3 Intravenous - Market size and forecast 2022-2027
o Exhibit 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
o 7.4 Inhalational - Market size and forecast 2022-2027
o Exhibit 51: Chart on Inhalational - Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Inhalational - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Inhalational - Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Inhalational - Year-over-year growth 2022-2027 (%)
o 7.5 Others - Market size and forecast 2022-2027
o Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Route of Administration
o Exhibit 59: Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share by geography 2022-2027 (%)
o Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 India - Market size and forecast 2022-2027
o Exhibit 97: Chart on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on India - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on India - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on India - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 101: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 108: AbbVie Inc. - Overview
o Exhibit 109: AbbVie Inc. - Product / Service
o Exhibit 110: AbbVie Inc. - Key news
o Exhibit 111: AbbVie Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 112: AstraZeneca Plc - Overview
o Exhibit 113: AstraZeneca Plc - Product / Service
o Exhibit 114: AstraZeneca Plc - Key news
o Exhibit 115: AstraZeneca Plc - Key offerings
o 12.5 Avet Pharmaceuticals Inc.
o Exhibit 116: Avet Pharmaceuticals Inc. - Overview
o Exhibit 117: Avet Pharmaceuticals Inc. - Product / Service
o Exhibit 118: Avet Pharmaceuticals Inc. - Key offerings
o 12.6 B Braun Melsungen AG
o Exhibit 119: B Braun Melsungen AG - Overview
o Exhibit 120: B Braun Melsungen AG - Business segments
o Exhibit 121: B Braun Melsungen AG - Key news
o Exhibit 122: B Braun Melsungen AG - Key offerings
o Exhibit 123: B Braun Melsungen AG - Segment focus
o 12.7 Baxter International Inc.
o Exhibit 124: Baxter International Inc. - Overview
o Exhibit 125: Baxter International Inc. - Business segments
o Exhibit 126: Baxter International Inc. - Key news
o Exhibit 127: Baxter International Inc. - Key offerings
o Exhibit 128: Baxter International Inc. - Segment focus
o 12.8 Eisai Co. Ltd.
o Exhibit 129: Eisai Co. Ltd. - Overview
o Exhibit 130: Eisai Co. Ltd. - Business segments
o Exhibit 131: Eisai Co. Ltd. - Key offerings
o Exhibit 132: Eisai Co. Ltd. - Segment focus
o 12.9 Fresenius SE and Co. KGaA
o Exhibit 133: Fresenius SE and Co. KGaA - Overview
o Exhibit 134: Fresenius SE and Co. KGaA - Business segments
o Exhibit 135: Fresenius SE and Co. KGaA - Key news
o Exhibit 136: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 137: Fresenius SE and Co. KGaA - Segment focus
o 12.10 Glenmark Pharmaceuticals Ltd.
o Exhibit 138: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 139: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 140: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.11 Hikma Pharmaceuticals Plc
o Exhibit 141: Hikma Pharmaceuticals Plc - Overview
o Exhibit 142: Hikma Pharmaceuticals Plc - Business segments
o Exhibit 143: Hikma Pharmaceuticals Plc - Key offerings
o Exhibit 144: Hikma Pharmaceuticals Plc - Segment focus
o 12.12 Maruishi Pharmaceutical Co. Ltd.
o Exhibit 145: Maruishi Pharmaceutical Co. Ltd. - Overview
o Exhibit 146: Maruishi Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 147: Maruishi Pharmaceutical Co. Ltd. - Key offerings
o 12.13 Merck and Co. Inc.
o Exhibit 148: Merck and Co. Inc. - Overview
o Exhibit 149: Merck and Co. Inc. - Business segments
o Exhibit 150: Merck and Co. Inc. - Key news
o Exhibit 151: Merck and Co. Inc. - Key offerings
o Exhibit 152: Merck and Co. Inc. - Segment focus
o 12.14 Novartis AG
o Exhibit 153: Novartis AG - Overview
o Exhibit 154: Novartis AG - Business segments
o Exhibit 155: Novartis AG - Key offerings
o Exhibit 156: Novartis AG - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 157: Pfizer Inc. - Overview
o Exhibit 158: Pfizer Inc. - Product / Service
o Exhibit 159: Pfizer Inc. - Key news
o Exhibit 160: Pfizer Inc. - Key offerings
o 12.16 Piramal Enterprises Ltd.
o Exhibit 161: Piramal Enterprises Ltd. - Overview
o Exhibit 162: Piramal Enterprises Ltd. - Business segments
o Exhibit 163: Piramal Enterprises Ltd. - Key offerings
o Exhibit 164: Piramal Enterprises Ltd. - Segment focus
o 12.17 Septodont Holding
o Exhibit 165: Septodont Holding - Overview
o Exhibit 166: Septodont Holding - Product / Service
o Exhibit 167: Septodont Holding - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global anesthesia drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on General anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on General anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on General anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Local and regional anesthesia - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Local and regional anesthesia - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits44: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Route of Administration
Exhibits46: Data Table on Comparison by Route of Administration
Exhibits47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Inhalational - Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Inhalational - Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Inhalational - Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Route of Administration ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share by geography 2022-2027 (%)
Exhibits62: Data Table on Market share by geography 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity by geography ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: AbbVie Inc. - Overview
Exhibits109: AbbVie Inc. - Product / Service
Exhibits110: AbbVie Inc. - Key news
Exhibits111: AbbVie Inc. - Key offerings
Exhibits112: AstraZeneca Plc - Overview
Exhibits113: AstraZeneca Plc - Product / Service
Exhibits114: AstraZeneca Plc - Key news
Exhibits115: AstraZeneca Plc - Key offerings
Exhibits116: Avet Pharmaceuticals Inc. - Overview
Exhibits117: Avet Pharmaceuticals Inc. - Product / Service
Exhibits118: Avet Pharmaceuticals Inc. - Key offerings
Exhibits119: B Braun Melsungen AG - Overview
Exhibits120: B Braun Melsungen AG - Business segments
Exhibits121: B Braun Melsungen AG - Key news
Exhibits122: B Braun Melsungen AG - Key offerings
Exhibits123: B Braun Melsungen AG - Segment focus
Exhibits124: Baxter International Inc. - Overview
Exhibits125: Baxter International Inc. - Business segments
Exhibits126: Baxter International Inc. - Key news
Exhibits127: Baxter International Inc. - Key offerings
Exhibits128: Baxter International Inc. - Segment focus
Exhibits129: Eisai Co. Ltd. - Overview
Exhibits130: Eisai Co. Ltd. - Business segments
Exhibits131: Eisai Co. Ltd. - Key offerings
Exhibits132: Eisai Co. Ltd. - Segment focus
Exhibits133: Fresenius SE and Co. KGaA - Overview
Exhibits134: Fresenius SE and Co. KGaA - Business segments
Exhibits135: Fresenius SE and Co. KGaA - Key news
Exhibits136: Fresenius SE and Co. KGaA - Key offerings
Exhibits137: Fresenius SE and Co. KGaA - Segment focus
Exhibits138: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits139: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits140: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits141: Hikma Pharmaceuticals Plc - Overview
Exhibits142: Hikma Pharmaceuticals Plc - Business segments
Exhibits143: Hikma Pharmaceuticals Plc - Key offerings
Exhibits144: Hikma Pharmaceuticals Plc - Segment focus
Exhibits145: Maruishi Pharmaceutical Co. Ltd. - Overview
Exhibits146: Maruishi Pharmaceutical Co. Ltd. - Product / Service
Exhibits147: Maruishi Pharmaceutical Co. Ltd. - Key offerings
Exhibits148: Merck and Co. Inc. - Overview
Exhibits149: Merck and Co. Inc. - Business segments
Exhibits150: Merck and Co. Inc. - Key news
Exhibits151: Merck and Co. Inc. - Key offerings
Exhibits152: Merck and Co. Inc. - Segment focus
Exhibits153: Novartis AG - Overview
Exhibits154: Novartis AG - Business segments
Exhibits155: Novartis AG - Key offerings
Exhibits156: Novartis AG - Segment focus
Exhibits157: Pfizer Inc. - Overview
Exhibits158: Pfizer Inc. - Product / Service
Exhibits159: Pfizer Inc. - Key news
Exhibits160: Pfizer Inc. - Key offerings
Exhibits161: Piramal Enterprises Ltd. - Overview
Exhibits162: Piramal Enterprises Ltd. - Business segments
Exhibits163: Piramal Enterprises Ltd. - Key offerings
Exhibits164: Piramal Enterprises Ltd. - Segment focus
Exhibits165: Septodont Holding - Overview
Exhibits166: Septodont Holding - Product / Service
Exhibits167: Septodont Holding - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations